Global

Pharmaceutical Sciences Experts

Wahajuddin


Central Drug Research Institute (CDRI)
CSIR
India

Biography

Wahajuddin is a scientist in Pharmacokinetics Metabolism Division at Central Drug Research Institute Council for Scientific and Industrial Research Govt of India Lucknow India. He has studied at National Institute of Pharmaceutical Education and Research an institute of national importance under the aegis of ministry of chemicals and fertilizers Govt of India S A S Nagar Punjab India. Wahajuddin is also working as course coordinator for MS Pharm. Pharmaceutics at the newly established National Institute of Pharmaceutical Education and Research, which is an institute of national importance under the aegis of the Ministry of Chemicals and Fertilizers, Government of India. He is also registered patent agent at Indian Patent Office He is life member of many professional societies viz Indian Pharmacological Society Indian Society of Mass Spectrometry etc.

Research Interest

Bio-analysis: Bio-analytical method development and validation, as per the regulatory US FDA, ICH etc. guidelines, on HPLC and LC-MS/MS platform for quantitative determination of small molecules NCEs or Drugs and/or metabolites in different biological matrices  Pharmacokinetic studies: Characterization of the in vivo pharmacokinetics bio-availability, dose-proportionality, gender variation, inter-species comparison  following oral and parenteral routes of administration in animal models. Toxicokinetic and tissue distribution studies to support regulatory toxicology Metabolism, Metabolite Identification and CYP Phenotyping: In vitro/in vivo Metabolism of new chemical entities and/or drugs using animal models, scaling preclinical and in-vitro data to predict events in humans for preliminary assessment of safe exposure levels, determination of the metabolite profiles of drug candidates using liver microsomes/human recombinant CYP450 isozymes, Identify Phase I or Phase II enzymes responsible for metabolite formation, predict drug interactions due to inhibition or induction of drug metabolizing enzymes.  Interaction Studies: Drug-drug, herb-drug and food-drug interaction studies for suggesting benefits (as potential combination)/risks of the same in therapies Biopharmaceutics: Permeability/Absorption Characterization Studies across Parallel Artificial Membrane Permeability Assay (PAMPA) and in situ rat model, Protein Binding and Simulated Gastro-intestinal Stability for new chemical entities/drugs

Global Experts from India

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America